{"transactions":[{"id":677351,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-08-24T21:00:26.000Z","date":"2026-06-12","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":3.97,"value":7940.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The original Form 4, filed on June 12, 2026, inadvertently used transaction code 'A' instead of transaction code 'P'. This amendment corrects the transaction code."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs"}],"balance_after":152927,"source":{"system":"sec-edgar","filing":"0001193125-26-363747","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526363747/ownership.xml","form_type":"4/A","original_submission_date":"2026-06-12"}},{"id":739762,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-06-12T20:30:05.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":3.97,"value":7940.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs"}],"balance_after":152927,"source":{"system":"sec-edgar","filing":"0001193125-26-269544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526269544/ownership.xml","form_type":"4"}},{"id":743206,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":39675,"kind":"person","name":"Woody Joseph Fralin","position":1,"cik":"0001709989","reported_name":"Woody Joseph Fralin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:17:19.000Z","date":"2026-06-09","kind":"purchase","planned":false,"acquired":true,"shares":5200,"price":4,"value":20800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs"}],"balance_after":107961,"source":{"system":"sec-edgar","filing":"0001193125-26-266397","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709989/000119312526266397/ownership.xml","form_type":"4"}},{"id":744688,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":39675,"kind":"person","name":"Woody Joseph Fralin","position":1,"cik":"0001709989","reported_name":"Woody Joseph Fralin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T20:58:26.000Z","date":"2026-06-09","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.18,"value":20900.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs"}],"balance_after":102761,"source":{"system":"sec-edgar","filing":"0001193125-26-263968","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709989/000119312526263968/ownership.xml","form_type":"4"}},{"id":744687,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":39675,"kind":"person","name":"Woody Joseph Fralin","position":1,"cik":"0001709989","reported_name":"Woody Joseph Fralin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T20:58:26.000Z","date":"2026-06-09","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.2,"value":21000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs"}],"balance_after":97761,"source":{"system":"sec-edgar","filing":"0001193125-26-263968","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709989/000119312526263968/ownership.xml","form_type":"4"}},{"id":747979,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":39675,"kind":"person","name":"Woody Joseph Fralin","position":1,"cik":"0001709989","reported_name":"Woody Joseph Fralin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T21:00:12.000Z","date":"2026-06-03","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.0899,"value":20449.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs"}],"balance_after":92761,"source":{"system":"sec-edgar","filing":"0001709989-26-000011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709989/000170998926000011/ownership.xml","form_type":"4"}},{"id":747978,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":39675,"kind":"person","name":"Woody Joseph Fralin","position":1,"cik":"0001709989","reported_name":"Woody Joseph Fralin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T21:00:12.000Z","date":"2026-06-03","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.0999,"value":20499.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs"}],"balance_after":87761,"source":{"system":"sec-edgar","filing":"0001709989-26-000011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709989/000170998926000011/ownership.xml","form_type":"4"}},{"id":749301,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41261,"kind":"person","name":"McNamara Robert","position":1,"cik":"0001387652","reported_name":"McNamara Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-04T23:39:08.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":16133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On January 5, 2026, the Board of Directors approved a grant of 16,133 options to acquire 16,133 shares of Common Stock to each of its non-executive directors, with a grant date of January 20, 2026 (the \"Grant Date\") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $3.77. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."}],"balance_after":16133,"derivative":{"exercise_price":3.77,"exercise_date":"2027-01-20","expiration_date":"2036-01-20","underlying":"Common Stock","underlying_shares":16133},"source":{"system":"sec-edgar","filing":"0001387652-26-000001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1387652/000138765226000001/ownership.xml","form_type":"4"}},{"id":749300,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41261,"kind":"person","name":"McNamara Robert","position":1,"cik":"0001387652","reported_name":"McNamara Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T23:39:08.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":22214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 20, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":108985,"source":{"system":"sec-edgar","filing":"0001387652-26-000001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387652/000138765226000001/ownership.xml","form_type":"4"}},{"id":749605,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":39675,"kind":"person","name":"Woody Joseph Fralin","position":1,"cik":"0001709989","reported_name":"Woody Joseph Fralin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-04T23:10:02.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":16133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On January 5, 2026, the Board of Directors approved a grant of 16,133 options to acquire 16,133 shares of Common Stock to each of its non-executive directors, with a grant date of January 20, 2026 (the \"Grant Date\") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $3.77. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."}],"balance_after":16133,"derivative":{"exercise_price":3.77,"exercise_date":"2027-01-20","expiration_date":"2036-01-20","underlying":"Common Stock","underlying_shares":16133},"source":{"system":"sec-edgar","filing":"0001709989-26-000008","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709989/000170998926000008/ownership.xml","form_type":"4"}},{"id":749604,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":39675,"kind":"person","name":"Woody Joseph Fralin","position":1,"cik":"0001709989","reported_name":"Woody Joseph Fralin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-04T23:10:02.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":29446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On January 5, 2026, the Board of Directors approved a grant of 29,446 options to acquire 29,446 shares of Common Stock of the Company to Mr. Woody as a new non-executive director, with an effective grant date of January 5, 2026 and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on January 5, 2026 of $3.47. The grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date."}],"balance_after":29446,"derivative":{"exercise_price":3.47,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":29446},"source":{"system":"sec-edgar","filing":"0001709989-26-000008","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709989/000170998926000008/ownership.xml","form_type":"4"}},{"id":749603,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":39675,"kind":"person","name":"Woody Joseph Fralin","position":1,"cik":"0001709989","reported_name":"Woody Joseph Fralin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T23:10:02.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":22214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 20, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs"}],"balance_after":82761,"source":{"system":"sec-edgar","filing":"0001709989-26-000008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709989/000170998926000008/ownership.xml","form_type":"4"}},{"id":749602,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":39675,"kind":"person","name":"Woody Joseph Fralin","position":1,"cik":"0001709989","reported_name":"Woody Joseph Fralin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T23:10:02.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":40547,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments on the date 12 months following the grant date of January 5, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs"}],"balance_after":60547,"source":{"system":"sec-edgar","filing":"0001709989-26-000008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709989/000170998926000008/ownership.xml","form_type":"4"}},{"id":749153,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-04T23:09:40.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":16133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On January 5, 2026, the Board of Directors approved a grant of 16,133 options to acquire 16,133 shares of Common Stock to each of its non-executive directors, with a grant date of January 20, 2026 (the \"Grant Date\") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $3.77. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."}],"balance_after":16133,"derivative":{"exercise_price":3.77,"exercise_date":"2027-01-20","expiration_date":"2036-01-20","underlying":"Common Stock","underlying_shares":16133},"source":{"system":"sec-edgar","filing":"0001603289-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1603289/000160328926000002/ownership.xml","form_type":"4"}},{"id":749152,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-04T23:09:40.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":19063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On August 6, 2025, the Board of Directors approved a grant of 19,063 options to acquire 19,063 shares of Common Stock of the Company to Dr. Tarnoff as a new non-executive director, with an effective grant date of August 6, 2025 and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on August 6, 2025 of $5.36. The grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date."}],"balance_after":19063,"derivative":{"exercise_price":5.36,"expiration_date":"2035-08-06","underlying":"Common Stock","underlying_shares":19063},"source":{"system":"sec-edgar","filing":"0001603289-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1603289/000160328926000002/ownership.xml","form_type":"4"}},{"id":749151,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T23:09:40.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":22214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 20, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs"}],"balance_after":48464,"source":{"system":"sec-edgar","filing":"0001603289-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603289/000160328926000002/ownership.xml","form_type":"4"}},{"id":749150,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T23:09:40.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":26250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments on the date 12 months following the grant date of August 6, 2025. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs"}],"balance_after":26250,"source":{"system":"sec-edgar","filing":"0001603289-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603289/000160328926000002/ownership.xml","form_type":"4"}},{"id":749369,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41275,"kind":"person","name":"COOK JEREMY CURNOCK","position":1,"cik":"0001216486","reported_name":"COOK JEREMY CURNOCK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-04T23:09:11.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":16133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On January 5, 2026, the Board of Directors approved a grant of 16,133 options to acquire 16,133 shares of Common Stock to each of its non-executive directors, with a grant date of January 20, 2026 (the \"Grant Date\") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $3.77. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."}],"balance_after":16133,"derivative":{"exercise_price":3.77,"exercise_date":"2027-01-20","expiration_date":"2036-01-20","underlying":"Common Stock","underlying_shares":16133},"source":{"system":"sec-edgar","filing":"0001216486-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216486/000121648626000002/ownership.xml","form_type":"4"}},{"id":749368,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41275,"kind":"person","name":"COOK JEREMY CURNOCK","position":1,"cik":"0001216486","reported_name":"COOK JEREMY CURNOCK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T23:09:11.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":22214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 20, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":62050,"source":{"system":"sec-edgar","filing":"0001216486-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216486/000121648626000002/ownership.xml","form_type":"4"}},{"id":749716,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-04T23:08:50.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":16133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On January 5, 2026, the Board of Directors approved a grant of 16,133 options to acquire 16,133 shares of Common Stock to each of its non-executive directors, with a grant date of January 20, 2026 (the \"Grant Date\") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $3.77. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."}],"balance_after":16133,"derivative":{"exercise_price":3.77,"exercise_date":"2027-01-20","expiration_date":"2036-01-20","underlying":"Common Stock","underlying_shares":16133},"source":{"system":"sec-edgar","filing":"0001816242-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000181624226000002/ownership.xml","form_type":"4"}},{"id":749715,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T23:08:50.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":22214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 20, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 22,990 of the Issuer's CDIs. The Reporting Person's 22,990 CDIs translate into 4,598 of the shares of Common Stock set forth above."}],"balance_after":69148,"source":{"system":"sec-edgar","filing":"0001816242-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000181624226000002/ownership.xml","form_type":"4"}},{"id":749976,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":18820,"kind":"person","name":"REED JAN STERN","position":1,"cik":"0001124181","reported_name":"REED JAN STERN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-04T23:08:18.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":16133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On January 5, 2026, the Board of Directors approved a grant of 16,133 options to acquire 16,133 shares of Common Stock to each of its non-executive directors, with a grant date of January 20, 2026 (the \"Grant Date\") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $3.77. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."}],"balance_after":16133,"derivative":{"exercise_price":3.77,"exercise_date":"2027-01-20","expiration_date":"2036-01-20","underlying":"Common Stock","underlying_shares":16133},"source":{"system":"sec-edgar","filing":"0001124181-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124181/000112418126000002/ownership.xml","form_type":"4"}},{"id":749975,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":18820,"kind":"person","name":"REED JAN STERN","position":1,"cik":"0001124181","reported_name":"REED JAN STERN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T23:08:18.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":22214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 20, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":73225,"source":{"system":"sec-edgar","filing":"0001124181-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124181/000112418126000002/ownership.xml","form_type":"4"}},{"id":751824,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":39675,"kind":"person","name":"Woody Joseph Fralin","position":1,"cik":"0001709989","reported_name":"Woody Joseph Fralin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T20:30:16.000Z","date":"2026-06-02","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.2071,"value":21035.5,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001709989-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709989/000170998926000006/ownership.xml","form_type":"4"}},{"id":751823,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":39675,"kind":"person","name":"Woody Joseph Fralin","position":1,"cik":"0001709989","reported_name":"Woody Joseph Fralin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T20:30:16.000Z","date":"2026-06-02","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.1802,"value":20901.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001709989-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709989/000170998926000006/ownership.xml","form_type":"4"}},{"id":751822,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":39675,"kind":"person","name":"Woody Joseph Fralin","position":1,"cik":"0001709989","reported_name":"Woody Joseph Fralin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T20:30:16.000Z","date":"2026-06-01","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.26,"value":21300.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001709989-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709989/000170998926000006/ownership.xml","form_type":"4"}},{"id":751821,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":39675,"kind":"person","name":"Woody Joseph Fralin","position":1,"cik":"0001709989","reported_name":"Woody Joseph Fralin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T20:30:16.000Z","date":"2026-06-01","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.34,"value":21700.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001709989-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709989/000170998926000006/ownership.xml","form_type":"4"}},{"id":756977,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-06-01T20:39:06.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":3.0515,"value":15257.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2025 and ended on May 31, 2026 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 1, 2025 (the purchase date of the offering period)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2025 and ended on May 31, 2026 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 1, 2025 (the purchase date of the offering period)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs"}],"balance_after":150927,"source":{"system":"sec-edgar","filing":"0001193125-26-251588","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526251588/ownership.xml","form_type":"4"}},{"id":757026,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":42791,"kind":"person","name":"Vance Cary Guy","position":1,"cik":"0001608992","reported_name":"Vance Cary Guy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-06-01T20:37:59.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":3.0515,"value":15257.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2025 and ended on May 31, 2026 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 1, 2025 (the purchase date of the offering period)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2025 and ended on May 31, 2026 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 1, 2025 (the purchase date of the offering period)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":40771,"source":{"system":"sec-edgar","filing":"0001193125-26-251586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608992/000119312526251586/ownership.xml","form_type":"4"}},{"id":769954,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-05-20T20:30:06.000Z","date":"2026-05-20","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":4.26,"value":8520.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs"}],"balance_after":145927,"source":{"system":"sec-edgar","filing":"0001193125-26-232686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526232686/ownership.xml","form_type":"4"}},{"id":771978,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-05-19T20:30:02.000Z","date":"2026-05-19","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":4.24,"value":8480.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs"}],"balance_after":143927,"source":{"system":"sec-edgar","filing":"0001193125-26-230874","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526230874/ownership.xml","form_type":"4"}},{"id":848631,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-03-11T20:30:07.000Z","date":"2026-03-11","kind":"purchase","planned":false,"acquired":true,"shares":1800,"price":4.78,"value":8604.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs"}],"balance_after":141927,"source":{"system":"sec-edgar","filing":"0001193125-26-102263","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526102263/ownership.xml","form_type":"4"}},{"id":888063,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-02-23T21:30:08.000Z","date":"2026-02-19","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":4.15,"value":12450.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs."}],"balance_after":140127,"source":{"system":"sec-edgar","filing":"0001193125-26-064111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526064111/ownership.xml","form_type":"4"}},{"id":893291,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-02-19T21:38:20.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":155510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date of February 18, 2026."}],"balance_after":155510,"derivative":{"exercise_price":4.31,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":155510},"source":{"system":"sec-edgar","filing":"0001193125-26-059552","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526059552/ownership.xml","form_type":"4"}},{"id":893290,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-02-19T21:38:20.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":105470,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments beginning on the date 12 months following the grant date of February 18, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":137127,"source":{"system":"sec-edgar","filing":"0001193125-26-059552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526059552/ownership.xml","form_type":"4"}},{"id":892545,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":65613,"kind":"person","name":"KELSEY NICOLE","position":1,"cik":"0001714653","reported_name":"KELSEY NICOLE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-02-19T16:30:05.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":145060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date of February 18, 2026."}],"balance_after":145060,"derivative":{"exercise_price":4.31,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":145060},"source":{"system":"sec-edgar","filing":"0001193125-26-059502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714653/000119312526059502/ownership.xml","form_type":"4"}},{"id":892544,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":65613,"kind":"person","name":"KELSEY NICOLE","position":1,"cik":"0001714653","reported_name":"KELSEY NICOLE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-19T16:30:05.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":98390,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments beginning on the date 12 months following the grant date of February 18, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":98390,"source":{"system":"sec-edgar","filing":"0001193125-26-059502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714653/000119312526059502/ownership.xml","form_type":"4"}},{"id":1052675,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41261,"kind":"person","name":"McNamara Robert","position":1,"cik":"0001387652","reported_name":"McNamara Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-29T20:30:09.000Z","date":"2025-08-28","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.5,"value":45000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs"}],"balance_after":86771,"source":{"system":"sec-edgar","filing":"0000950170-25-112234","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387652/000095017025112234/ownership.xml","form_type":"4"}},{"id":1055613,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-08-26T20:30:23.000Z","date":"2025-08-26","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":4.52,"value":9040.0,"ownership":{"direct":true},"balance_after":31657,"source":{"system":"sec-edgar","filing":"0000950170-25-111467","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017025111467/ownership.xml","form_type":"4"}},{"id":1060048,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41261,"kind":"person","name":"McNamara Robert","position":1,"cik":"0001387652","reported_name":"McNamara Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-20T22:11:04.000Z","date":"2025-08-19","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":5,"value":50000.0,"ownership":{"direct":true},"balance_after":76771,"source":{"system":"sec-edgar","filing":"0000950170-25-110499","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387652/000095017025110499/ownership.xml","form_type":"4"}},{"id":1068833,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-08-12T20:30:15.000Z","date":"2025-08-12","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":4.81,"value":9620.0,"ownership":{"direct":true},"balance_after":29657,"source":{"system":"sec-edgar","filing":"0000950170-25-107387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017025107387/ownership.xml","form_type":"4"}},{"id":1121277,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":42791,"kind":"person","name":"Vance Cary Guy","position":1,"cik":"0001608992","reported_name":"Vance Cary Guy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-05T21:00:40.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":4295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On January 6, 2025, the Board of Directors approved a grant of 4,295 options to acquire 4,295 shares of Common Stock to each of its non-executive directors, with a grant date of January 21, 2025 (the \"Grant Date\") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $8.73. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025."}],"balance_after":4295,"derivative":{"exercise_price":8.73,"exercise_date":"2026-01-21","expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":4295},"source":{"system":"sec-edgar","filing":"0000950170-25-082466","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608992/000095017025082466/ownership.xml","form_type":"4"}},{"id":1121276,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":42791,"kind":"person","name":"Vance Cary Guy","position":1,"cik":"0001608992","reported_name":"Vance Cary Guy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T21:00:40.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":10022,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 21, 2025. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":35771,"source":{"system":"sec-edgar","filing":"0000950170-25-082466","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608992/000095017025082466/ownership.xml","form_type":"4"}},{"id":1121762,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":18820,"kind":"person","name":"REED JAN STERN","position":1,"cik":"0001124181","reported_name":"REED JAN STERN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-05T20:55:41.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":4295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On January 6, 2025, the Board of Directors approved a grant of 4,295 options to acquire 4,295 shares of Common Stock to each of its non-executive directors, with a grant date of January 21, 2025 (the \"Grant Date\") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $8.73. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025."}],"balance_after":4295,"derivative":{"exercise_price":8.73,"exercise_date":"2026-01-21","expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":4295},"source":{"system":"sec-edgar","filing":"0000950170-25-082450","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124181/000095017025082450/ownership.xml","form_type":"4"}},{"id":1121761,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":18820,"kind":"person","name":"REED JAN STERN","position":1,"cik":"0001124181","reported_name":"REED JAN STERN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:55:41.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":10022,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 21, 2025. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":51011,"source":{"system":"sec-edgar","filing":"0000950170-25-082450","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124181/000095017025082450/ownership.xml","form_type":"4"}},{"id":1120982,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41261,"kind":"person","name":"McNamara Robert","position":1,"cik":"0001387652","reported_name":"McNamara Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-05T20:50:11.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":4295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On January 6, 2025, the Board of Directors approved a grant of 4,295 options to acquire 4,295 shares of Common Stock to each of its non-executive directors, with a grant date of January 21, 2025 (the \"Grant Date\") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $8.73. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025."}],"balance_after":4295,"derivative":{"exercise_price":8.73,"exercise_date":"2026-01-21","expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":4295},"source":{"system":"sec-edgar","filing":"0000950170-25-082439","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1387652/000095017025082439/ownership.xml","form_type":"4"}},{"id":1120981,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41261,"kind":"person","name":"McNamara Robert","position":1,"cik":"0001387652","reported_name":"McNamara Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:50:11.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":10022,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 21, 2025. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":66771,"source":{"system":"sec-edgar","filing":"0000950170-25-082439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387652/000095017025082439/ownership.xml","form_type":"4"}},{"id":1121054,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41275,"kind":"person","name":"COOK JEREMY CURNOCK","position":1,"cik":"0001216486","reported_name":"COOK JEREMY CURNOCK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-05T20:46:18.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":4295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On January 6, 2025, the Board of Directors approved a grant of 4,295 options to acquire 4,295 shares of Common Stock to each of its non-executive directors, with a grant date of January 21, 2025 (the \"Grant Date\") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $8.73. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025."}],"balance_after":4295,"derivative":{"exercise_price":8.73,"exercise_date":"2026-01-21","expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":4295},"source":{"system":"sec-edgar","filing":"0000950170-25-082428","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216486/000095017025082428/ownership.xml","form_type":"4"}},{"id":1121053,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41275,"kind":"person","name":"COOK JEREMY CURNOCK","position":1,"cik":"0001216486","reported_name":"COOK JEREMY CURNOCK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:46:18.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":10022,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 21, 2025. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":39836,"source":{"system":"sec-edgar","filing":"0000950170-25-082428","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216486/000095017025082428/ownership.xml","form_type":"4"}},{"id":1121477,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-05T20:41:59.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":4295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On January 6, 2025, the Board of Directors approved a grant of 4,295 options to acquire 4,295 shares of Common Stock to each of its non-executive directors, with a grant date of January 21, 2025 (the \"Grant Date\") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $8.73. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025."}],"balance_after":4295,"derivative":{"exercise_price":8.73,"exercise_date":"2026-01-21","expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":4295},"source":{"system":"sec-edgar","filing":"0000950170-25-082422","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000095017025082422/ownership.xml","form_type":"4"}},{"id":1121476,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:41:59.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":10022,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 21, 2025. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 22,990 of the Issuer's CDIs. The Reporting Person's 22,990 CDIs translate into 4,598 of the shares of Common Stock set forth above."}],"balance_after":46934,"source":{"system":"sec-edgar","filing":"0000950170-25-082422","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000095017025082422/ownership.xml","form_type":"4"}},{"id":1121474,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":78842,"kind":"person","name":"Panaccio Lou","position":1,"cik":"0001816237","reported_name":"Panaccio Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-05T16:35:39.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":4295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On January 6, 2025, the Board of Directors approved a grant of 4,295 options to acquire 4,295 shares of Common Stock to each of its non-executive directors, with a grant date of January 21, 2025 (the \"Grant Date\") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $8.73. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025."}],"balance_after":4295,"derivative":{"exercise_price":8.73,"exercise_date":"2026-01-21","expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":4295},"source":{"system":"sec-edgar","filing":"0000950170-25-082417","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816237/000095017025082417/ownership.xml","form_type":"4"}},{"id":1121473,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":78842,"kind":"person","name":"Panaccio Lou","position":1,"cik":"0001816237","reported_name":"Panaccio Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T16:35:39.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":10022,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 21, 2025. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 70,460 of the Issuer's CDIs. The Reporting Person holds 70,460 CDIs, which translate into 14,092 of the shares of Common Stock set forth above."}],"balance_after":56428,"source":{"system":"sec-edgar","filing":"0000950170-25-082417","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816237/000095017025082417/ownership.xml","form_type":"4"}},{"id":1121093,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":78835,"kind":"person","name":"CORBETT JAMES","position":1,"cik":"0001238620","reported_name":"CORBETT JAMES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-05T16:30:10.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":520000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On January 7, 2025, the Board of Directors approved a grant of 520,000 options to acquire 520,000 shares of Common Stock of the Company (the \"Common Stock\") to Mr. Corbett, with an effective grant date of January 21, 2025 (the \"Grant Date\") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $8.73. This grant was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These Stock Options vest in three equal annual installments beginning on the date 12 months following the grant date of January 21, 2025."}],"balance_after":520000,"derivative":{"exercise_price":8.73,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":520000},"source":{"system":"sec-edgar","filing":"0000950170-25-082389","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238620/000095017025082389/ownership.xml","form_type":"4"}},{"id":1127600,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-06-02T20:30:06.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":1923,"price":4.777,"value":9186.171,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2024 and ended on May 31, 2025 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 30, 2025 (the purchase date of the offering period)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2024 and ended on May 31, 2025 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 30, 2025 (the purchase date of the offering period)."}],"balance_after":27657,"source":{"system":"sec-edgar","filing":"0000950170-25-080304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017025080304/ownership.xml","form_type":"4"}},{"id":1214642,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41261,"kind":"person","name":"McNamara Robert","position":1,"cik":"0001387652","reported_name":"McNamara Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-10T20:30:06.000Z","date":"2025-03-06","kind":"purchase","planned":false,"acquired":true,"shares":11000,"price":8.3,"value":91300.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs"}],"balance_after":56749,"source":{"system":"sec-edgar","filing":"0000950170-25-036355","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387652/000095017025036355/ownership.xml","form_type":"4"}},{"id":1255271,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41261,"kind":"person","name":"McNamara Robert","position":1,"cik":"0001387652","reported_name":"McNamara Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-20T21:30:19.000Z","date":"2025-02-20","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":10.09,"value":100900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.89 to $10.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares of Common Stock purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs"}],"balance_after":45749,"source":{"system":"sec-edgar","filing":"0000950170-25-024211","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387652/000095017025024211/ownership.xml","form_type":"4"}},{"id":1255655,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-02-20T21:30:08.000Z","date":"2025-02-20","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":9.9,"value":9900.0,"ownership":{"direct":true},"balance_after":25734,"source":{"system":"sec-edgar","filing":"0000950170-25-024204","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017025024204/ownership.xml","form_type":"4"}},{"id":1259813,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-02-19T21:30:04.000Z","date":"2025-02-19","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":10.25,"value":10250.0,"ownership":{"direct":true},"balance_after":24734,"source":{"system":"sec-edgar","filing":"0000950170-25-023233","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017025023233/ownership.xml","form_type":"4"}},{"id":1291935,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-29T21:57:48.000Z","date":"2024-12-09","kind":"purchase","planned":false,"acquired":true,"shares":486,"price":13.15,"value":6390.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects 2,430 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of the Issuer's common stock and have all the rights and privileges of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase price was converted from A$4.11, using the exchange rate as in effect on the date of the transaction, and reflects the 5:1 consolidation ratio applied in converting CDIs to shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 22,990 of the Issuer's CDIs. The Reporting Person's 22,990 CDIs translate into 4,598 of the shares of Common Stock set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes unvested RSUs."}],"balance_after":36912,"source":{"system":"sec-edgar","filing":"0000950170-25-010560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000095017025010560/ownership.xml","form_type":"4"}},{"id":1297498,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-01-22T21:30:05.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date."}],"balance_after":150000,"derivative":{"exercise_price":8.73,"expiration_date":"2034-01-21","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-25-007794","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017025007794/ownership.xml","form_type":"4"}},{"id":1297199,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":65613,"kind":"person","name":"KELSEY NICOLE","position":1,"cik":"0001714653","reported_name":"KELSEY NICOLE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-01-22T16:30:03.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date."}],"balance_after":65000,"derivative":{"exercise_price":8.73,"expiration_date":"2034-01-21","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000950170-25-007793","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714653/000095017025007793/ownership.xml","form_type":"4"}},{"id":1341544,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-12-05T22:00:07.000Z","date":"2024-12-05","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":12.4,"value":6200.0,"ownership":{"direct":true},"balance_after":23734,"source":{"system":"sec-edgar","filing":"0000950170-24-133748","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024133748/ownership.xml","form_type":"4"}},{"id":1341543,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-12-05T22:00:07.000Z","date":"2024-12-05","kind":"purchase","planned":false,"acquired":true,"shares":475,"price":12.53,"value":5951.75,"ownership":{"direct":true},"balance_after":23234,"source":{"system":"sec-edgar","filing":"0000950170-24-133748","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024133748/ownership.xml","form_type":"4"}},{"id":1341542,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-12-05T22:00:07.000Z","date":"2024-11-29","kind":"grant","planned":false,"acquired":true,"shares":785,"price":7.83,"value":6146.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period which began on June 1, 2024 and which ended on November 30, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 3, 2024 (the purchase date of the offering period)."}],"balance_after":22759,"source":{"system":"sec-edgar","filing":"0000950170-24-133748","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024133748/ownership.xml","form_type":"4"}},{"id":1427410,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41261,"kind":"person","name":"McNamara Robert","position":1,"cik":"0001387652","reported_name":"McNamara Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-20T20:30:02.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":9,"value":90000.0,"ownership":{"direct":true},"balance_after":35749,"source":{"system":"sec-edgar","filing":"0000950170-24-099134","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387652/000095017024099134/ownership.xml","form_type":"4"}},{"id":1488564,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-06T23:36:12.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":3943,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3943,"derivative":{"exercise_price":9.51,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0000950170-24-070118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000095017024070118/ownership.xml","form_type":"4"}},{"id":1488563,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T23:36:12.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":9200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 20,560 of the Issuer's CDIs. The Reporting Person's 20,560 CDIs translate into 4,112 of the shares of Common Stock set forth above."}],"balance_after":36426,"source":{"system":"sec-edgar","filing":"0000950170-24-070118","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000095017024070118/ownership.xml","form_type":"4"}},{"id":1488172,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41275,"kind":"person","name":"COOK JEREMY CURNOCK","position":1,"cik":"0001216486","reported_name":"COOK JEREMY CURNOCK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-06T23:29:30.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":3943,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3943,"derivative":{"exercise_price":9.51,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":3943},"source":{"system":"sec-edgar","filing":"0000950170-24-070114","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216486/000095017024070114/ownership.xml","form_type":"4"}},{"id":1488171,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41275,"kind":"person","name":"COOK JEREMY CURNOCK","position":1,"cik":"0001216486","reported_name":"COOK JEREMY CURNOCK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T23:29:30.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":9200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":29814,"source":{"system":"sec-edgar","filing":"0000950170-24-070114","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216486/000095017024070114/ownership.xml","form_type":"4"}},{"id":1488677,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":18820,"kind":"person","name":"REED JAN STERN","position":1,"cik":"0001124181","reported_name":"REED JAN STERN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-06T23:21:24.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":3943,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3943,"derivative":{"exercise_price":9.51,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":3943},"source":{"system":"sec-edgar","filing":"0000950170-24-070102","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124181/000095017024070102/ownership.xml","form_type":"4"}},{"id":1488676,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":18820,"kind":"person","name":"REED JAN STERN","position":1,"cik":"0001124181","reported_name":"REED JAN STERN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T23:21:24.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":9200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":40989,"source":{"system":"sec-edgar","filing":"0000950170-24-070102","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124181/000095017024070102/ownership.xml","form_type":"4"}},{"id":1488123,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41261,"kind":"person","name":"McNamara Robert","position":1,"cik":"0001387652","reported_name":"McNamara Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-06T23:14:42.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":3943,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3943,"derivative":{"exercise_price":9.51,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":3943},"source":{"system":"sec-edgar","filing":"0000950170-24-070096","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1387652/000095017024070096/ownership.xml","form_type":"4"}},{"id":1488122,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41261,"kind":"person","name":"McNamara Robert","position":1,"cik":"0001387652","reported_name":"McNamara Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T23:14:42.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":9200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":25749,"source":{"system":"sec-edgar","filing":"0000950170-24-070096","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387652/000095017024070096/ownership.xml","form_type":"4"}},{"id":1488389,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":42791,"kind":"person","name":"Vance Cary Guy","position":1,"cik":"0001608992","reported_name":"Vance Cary Guy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-06T23:05:39.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":3943,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3943,"derivative":{"exercise_price":9.51,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":3943},"source":{"system":"sec-edgar","filing":"0000950170-24-070089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608992/000095017024070089/ownership.xml","form_type":"4"}},{"id":1488388,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":42791,"kind":"person","name":"Vance Cary Guy","position":1,"cik":"0001608992","reported_name":"Vance Cary Guy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T23:05:39.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":9200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":25749,"source":{"system":"sec-edgar","filing":"0000950170-24-070089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608992/000095017024070089/ownership.xml","form_type":"4"}},{"id":1488562,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":78842,"kind":"person","name":"Panaccio Lou","position":1,"cik":"0001816237","reported_name":"Panaccio Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-06T20:48:06.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":3943,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3943,"derivative":{"exercise_price":9.51,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":3943},"source":{"system":"sec-edgar","filing":"0000950170-24-070155","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816237/000095017024070155/ownership.xml","form_type":"4"}},{"id":1488561,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":78842,"kind":"person","name":"Panaccio Lou","position":1,"cik":"0001816237","reported_name":"Panaccio Lou","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:48:06.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":9200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 70,460 of the Issuer's CDIs. The Reporting Person holds 70,460 CDIs, which translate into 14,092 of the shares of Common Stock set forth above."}],"balance_after":46406,"source":{"system":"sec-edgar","filing":"0000950170-24-070155","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816237/000095017024070155/ownership.xml","form_type":"4"}},{"id":1488201,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":78835,"kind":"person","name":"CORBETT JAMES","position":1,"cik":"0001238620","reported_name":"CORBETT JAMES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-06T19:02:32.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to Mr. Corbett's Employment Agreement, he is eligible for annual equity grants. On January 3, 2024, the Board of Directors approved a grant of 350,000 options to acquire 350,000 shares of Common Stock of the Company to Mr. Corbett, with an effective grant date of January 3, 2024 and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on January 3, 2024 of $12.64. The grant was subject to the approval of the Company's stockholders, which was obtained on June 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These Stock Options vest in three equal annual installments beginning on the date 12 months following the grant date of January 3, 2024."}],"balance_after":350000,"derivative":{"exercise_price":12.64,"expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0000950170-24-070082","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238620/000095017024070082/ownership.xml","form_type":"4"}},{"id":1495071,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-06-03T20:27:02.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":2240,"price":8.1685,"value":18297.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2023 and ending on May 31, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 31, 2024 (the purchase date of the offering period)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2023 and ending on May 31, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 31, 2024 (the purchase date of the offering period)."}],"balance_after":21974,"source":{"system":"sec-edgar","filing":"0000950170-24-068006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024068006/ownership.xml","form_type":"4"}},{"id":1495070,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-06-03T20:27:02.000Z","date":"2024-05-30","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":8.6,"value":4300.0,"ownership":{"direct":true},"balance_after":19734,"source":{"system":"sec-edgar","filing":"0000950170-24-068006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024068006/ownership.xml","form_type":"4"}},{"id":1495069,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-06-03T20:27:02.000Z","date":"2024-05-30","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":9.2,"value":4600.0,"ownership":{"direct":true},"balance_after":19234,"source":{"system":"sec-edgar","filing":"0000950170-24-068006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024068006/ownership.xml","form_type":"4"}},{"id":1495251,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":90344,"kind":"person","name":"Shiroma Donna","position":1,"cik":"0001816251","reported_name":"Shiroma Donna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-06-03T16:34:19.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":2225,"price":8.1685,"value":18174.9125,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2023 and ending on May 31, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 31, 2024 (the purchase date of the offering period)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2023 and ending on May 31, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 31, 2024 (the purchase date of the offering period)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs"}],"balance_after":45951,"source":{"system":"sec-edgar","filing":"0000950170-24-068048","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816251/000095017024068048/ownership.xml","form_type":"4"}},{"id":1612247,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-02-28T21:04:52.000Z","date":"2024-02-28","kind":"purchase","planned":false,"acquired":true,"shares":250,"price":17.43,"value":4357.5,"ownership":{"direct":true},"balance_after":18734,"source":{"system":"sec-edgar","filing":"0000950170-24-022050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024022050/ownership.xml","form_type":"4"}},{"id":1612246,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-02-28T21:04:52.000Z","date":"2024-02-28","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":17.38,"value":17380.0,"ownership":{"direct":true},"balance_after":18484,"source":{"system":"sec-edgar","filing":"0000950170-24-022050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024022050/ownership.xml","form_type":"4"}},{"id":1685448,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-01-05T22:49:33.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These Stock Options vest in three equal annual installments beginning with the first anniversary of the grant date."}],"balance_after":125000,"derivative":{"exercise_price":12.64,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-24-002565","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024002565/ownership.xml","form_type":"4"}},{"id":1685625,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":90344,"kind":"person","name":"Shiroma Donna","position":1,"cik":"0001816251","reported_name":"Shiroma Donna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-01-05T17:51:10.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date."}],"balance_after":100000,"derivative":{"exercise_price":12.64,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-24-002570","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816251/000095017024002570/ownership.xml","form_type":"4"}},{"id":1685624,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":90344,"kind":"person","name":"Shiroma Donna","position":1,"cik":"0001816251","reported_name":"Shiroma Donna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-01-05T17:51:10.000Z","date":"2023-11-30","kind":"grant","planned":false,"acquired":true,"shares":1469,"price":9.06,"value":13309.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase which began July 1, 2023 and ended November 30, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Company's stock on November 30, 2023 (the purchase date of the offering period)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase which began July 1, 2023 and ended November 30, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Company's stock on November 30, 2023 (the purchase date of the offering period)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs"}],"balance_after":43726,"source":{"system":"sec-edgar","filing":"0000950170-24-002570","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816251/000095017024002570/ownership.xml","form_type":"4"}},{"id":1699399,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":78835,"kind":"person","name":"CORBETT JAMES","position":1,"cik":"0001238620","reported_name":"CORBETT JAMES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common","published_at":"2023-12-27T17:02:26.000Z","date":"2023-12-26","kind":"sale","planned":false,"acquired":false,"shares":1445,"price":13.29,"value":19204.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold to cover tax obligation incurred by the Reporting Person upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares sold to cover tax obligation incurred by the Reporting Person upon the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs"}],"balance_after":11580,"source":{"system":"sec-edgar","filing":"0000950170-23-073346","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238620/000095017023073346/ownership.xml","form_type":"4"}},{"id":1700699,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41275,"kind":"person","name":"COOK JEREMY CURNOCK","position":1,"cik":"0001216486","reported_name":"COOK JEREMY CURNOCK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common","published_at":"2023-12-22T22:01:07.000Z","date":"2023-12-21","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":12.49,"value":31225.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold to cover UK tax obligation incurred by the Reporting Person upon the vesting of RSUs"},{"field":"shares","element":"transactionShares","label":"F2","text":"The original Form 4, filed on December 14, 2023, is being amended by this Form 4 to correct an administrative error, which misreported a sale of common stock to cover taxes for vesting of RSUs on the wrong date. The sale of the stock was reported on December 13, 2023, however, the actual sale occured on December 21, 2023. This Form 4 reflects the correction to the date, price and number of shares sold in the transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The original Form 4, filed on December 14, 2023, is being amended by this Form 4 to correct an administrative error, which misreported a sale of common stock to cover taxes for vesting of RSUs on the wrong date. The sale of the stock was reported on December 13, 2023, however, the actual sale occured on December 21, 2023. This Form 4 reflects the correction to the date, price and number of shares sold in the transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.39 to $12.64. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The original Form 4, filed on December 14, 2023, is being amended by this Form 4 to correct an administrative error, which misreported a sale of common stock to cover taxes for vesting of RSUs on the wrong date. The sale of the stock was reported on December 13, 2023, however, the actual sale occured on December 21, 2023. This Form 4 reflects the correction to the date, price and number of shares sold in the transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes unvested RSUs"}],"balance_after":20614,"source":{"system":"sec-edgar","filing":"0000950170-23-072730","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216486/000095017023072730/ownership.xml","form_type":"4/A","original_submission_date":"2023-12-14"}},{"id":1710768,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41275,"kind":"person","name":"COOK JEREMY CURNOCK","position":1,"cik":"0001216486","reported_name":"COOK JEREMY CURNOCK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common","published_at":"2023-12-14T22:01:31.000Z","date":"2023-12-13","kind":"sale","planned":false,"acquired":false,"shares":2518,"price":12.27,"value":30895.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares only sold to cover UK tax obligation incurred by the Reporting Person upon the vesting of RSUs"},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares only sold to cover UK tax obligation incurred by the Reporting Person upon the vesting of RSUs"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs"}],"balance_after":20596,"source":{"system":"sec-edgar","filing":"0000950170-23-070445","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216486/000095017023070445/ownership.xml","form_type":"4"}},{"id":1714224,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-12-12T21:37:38.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":950,"price":12.45,"value":11827.5,"ownership":{"direct":true},"balance_after":17484,"source":{"system":"sec-edgar","filing":"0000950170-23-069750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023069750/ownership.xml","form_type":"4"}},{"id":1723769,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-12-05T00:06:26.000Z","date":"2023-12-01","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":10.68,"value":5340.0,"ownership":{"direct":true},"balance_after":16534,"source":{"system":"sec-edgar","filing":"0000950170-23-067875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023067875/ownership.xml","form_type":"4"}},{"id":1723768,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-12-05T00:06:26.000Z","date":"2023-11-30","kind":"grant","planned":false,"acquired":true,"shares":1034,"price":9.061,"value":9369.074,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on July 1, 2023 and ending on November 30, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Company's stock on November 30, 2023 (the purchase date of the offering period)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on July 1, 2023 and ending on November 30, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Company's stock on November 30, 2023 (the purchase date of the offering period)."}],"balance_after":16034,"source":{"system":"sec-edgar","filing":"0000950170-23-067875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023067875/ownership.xml","form_type":"4"}},{"id":1732571,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-11-21T21:15:15.000Z","date":"2023-11-21","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":10.26,"value":10260.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0000950170-23-065502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023065502/ownership.xml","form_type":"4"}},{"id":1732570,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-11-21T21:15:15.000Z","date":"2023-11-21","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":10.3,"value":10300.0,"ownership":{"direct":true},"balance_after":14000,"source":{"system":"sec-edgar","filing":"0000950170-23-065502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023065502/ownership.xml","form_type":"4"}},{"id":1738985,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-11-16T19:38:24.000Z","date":"2023-11-15","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":12.45,"value":12450.0,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0000950170-23-064444","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023064444/ownership.xml","form_type":"4"}},{"id":1738984,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-11-16T19:38:24.000Z","date":"2023-11-16","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":12.15,"value":12150.0,"ownership":{"direct":true},"balance_after":12000,"source":{"system":"sec-edgar","filing":"0000950170-23-064444","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023064444/ownership.xml","form_type":"4"}},{"id":1740635,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-11-15T21:31:51.000Z","date":"2023-11-15","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":13.25,"value":13250.0,"ownership":{"direct":true},"balance_after":11000,"source":{"system":"sec-edgar","filing":"0000950170-23-064208","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023064208/ownership.xml","form_type":"4"}},{"id":1740634,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-11-15T21:31:51.000Z","date":"2023-11-14","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":12.88,"value":12880.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000950170-23-064208","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023064208/ownership.xml","form_type":"4"}}],"next_cursor":"2023-11-15T21:31:51.000000Z,1740634"}